A Phase I Study of Intraparenchymal Therapy with Irinotecan Hydrocholride Drug-Eluting Beads (CM-BC2) as an adjuvant Therapy to Best Standards of Care in Patients with Recurrent, Surgically Resectable Glioblastoma Multiforme

  • Cruickshank, Garth (Principal Investigator)

Project Details

Short titleA Phase I Study of Intraparenchymal Therapy with Irinotecan Hydrocholride Drug-Eluting Beads (CM-BC2) as an adjuvant Therapy to Best Standards of Care in Patients with Recurrent, Surgically Resectable Glioblastoma Multiforme
StatusFinished
Effective start/end date23/03/12 → 22/03/15

Funding

  • BIOCOMATIBLES UK LTD